| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 890 | 2018 |
| Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array RA Eeles, AAA Olama, S Benlloch, EJ Saunders, DA Leongamornlert, ... Nature genetics 45 (4), 385-391, 2013 | 690 | 2013 |
| A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer AA Al Olama, Z Kote-Jarai, SI Berndt, DV Conti, F Schumacher, Y Han, ... Nature genetics 46 (10), 1103-1109, 2014 | 546 | 2014 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 393 | 2021 |
| Personalized early detection and prevention of breast cancer: ENVISION consensus statement N Pashayan, AC Antoniou, U Ivanus, LJ Esserman, DF Easton, D French, ... Nature reviews Clinical oncology 17 (11), 687-705, 2020 | 362 | 2020 |
| Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model N Pashayan, S Morris, FJ Gilbert, PDP Pharoah JAMA oncology 4 (11), 1504-1510, 2018 | 291 | 2018 |
| Association analyses identify 31 new risk loci for colorectal cancer susceptibility PJ Law, M Timofeeva, C Fernandez-Rozadilla, P Broderick, J Studd, ... Nature communications 10 (1), 2154, 2019 | 234 | 2019 |
| Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types SP Kar, J Beesley, A Amin Al Olama, K Michailidou, J Tyrer, ZS Kote-Jarai, ... Cancer discovery 6 (9), 1052-1067, 2016 | 202 | 2016 |
| Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts TM Seibert, CC Fan, Y Wang, V Zuber, R Karunamuni, JK Parsons, ... bmj 360, 2018 | 195 | 2018 |
| Polygenic susceptibility to prostate and breast cancer: implications for personalised screening N Pashayan, SW Duffy, S Chowdhury, T Dent, H Burton, DE Neal, ... British journal of cancer 104 (10), 1656-1663, 2011 | 188 | 2011 |
| Epigenome-based cancer risk prediction: rationale, opportunities and challenges M Widschwendter, A Jones, I Evans, D Reisel, J Dillner, K Sundström, ... Nature reviews Clinical oncology 15 (5), 292-309, 2018 | 165 | 2018 |
| Public health implications from COGS and potential for risk stratification and screening H Burton, S Chowdhury, T Dent, A Hall, N Pashayan, P Pharoah Nature genetics 45 (4), 349-351, 2013 | 156 | 2013 |
| Large-scale transcriptome-wide association study identifies new prostate cancer risk regions N Mancuso, S Gayther, A Gusev, W Zheng, KL Penney, Z Kote-Jarai, ... Nature communications 9 (1), 4079, 2018 | 151 | 2018 |
| Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor K Litchfield, M Levy, G Orlando, C Loveday, PJ Law, G Migliorini, ... Nature genetics 49 (7), 1133-1140, 2017 | 143 | 2017 |
| Shared heritability and functional enrichment across six solid cancers X Jiang, HK Finucane, FR Schumacher, SL Schmit, JP Tyrer, Y Han, ... Nature communications 10 (1), 431, 2019 | 129 | 2019 |
| Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma M Went, A Sud, A Försti, BM Halvarsson, N Weinhold, S Kimber, ... Nature communications 9 (1), 3707, 2018 | 129 | 2018 |
| The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium NM Davies, TR Gaunt, SJ Lewis, J Holly, JL Donovan, FC Hamdy, ... Cancer Causes & Control 26, 1603-1616, 2015 | 129 | 2015 |
| The impact of the Covid-19 pandemic on breast cancer early detection and screening JD Figueroa, E Gray, N Pashayan, S Deandrea, A Karch, DB Vale, ... Preventive medicine 151, 106585, 2021 | 125 | 2021 |
| Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis N Pashayan, SW Duffy, DE Neal, FC Hamdy, JL Donovan, RM Martin, ... Genetics in Medicine 17 (10), 789-795, 2015 | 119 | 2015 |
| Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans A Amin Al Olama, T Dadaev, DJ Hazelett, Q Li, D Leongamornlert, ... Human molecular genetics 24 (19), 5589-5602, 2015 | 118 | 2015 |